240 related articles for article (PubMed ID: 21789189)
1. Dysregulated ΔNp63α inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytes.
Ha L; Ponnamperuma RM; Jay S; Ricci MS; Weinberg WC
PLoS One; 2011; 6(7):e21877. PubMed ID: 21789189
[TBL] [Abstract][Full Text] [Related]
2. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
Lin AW; Lowe SW
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
[TBL] [Abstract][Full Text] [Related]
4. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
5. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes.
Chaturvedi V; Cesnjaj M; Bacon P; Panella J; Choubey D; Diaz MO; Nickoloff BJ
Am J Pathol; 2003 Jan; 162(1):161-70. PubMed ID: 12507899
[TBL] [Abstract][Full Text] [Related]
6. Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
Vijayachandra K; Higgins W; Lee J; Glick A
Mol Carcinog; 2009 Mar; 48(3):181-186. PubMed ID: 18655107
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis.
Sakakibara N; Clavijo PE; Sievers C; Gray VC; King KE; George AL; Ponnamperuma RM; Walter BA; Chen Z; Van Waes C; Allen CT; Weinberg WC
Front Immunol; 2023; 14():1200970. PubMed ID: 37638000
[TBL] [Abstract][Full Text] [Related]
8. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
9. RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).
Lee AJ; Fraser E; Flowers B; Kim J; Wong K; Cataisson C; Liu H; Yang H; Lee MP; Yuspa SH; Li L
Mol Carcinog; 2021 Dec; 60(12):799-812. PubMed ID: 34534377
[TBL] [Abstract][Full Text] [Related]
10. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
11. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
12. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
13. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
14. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
15. An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer.
Salotti J; Sakchaisri K; Tourtellotte WG; Johnson PF
Mol Cell Biol; 2015 Mar; 35(5):866-83. PubMed ID: 25535333
[TBL] [Abstract][Full Text] [Related]
16. The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis.
Paramio JM; Segrelles C; Ruiz S; Martin-Caballero J; Page A; Martinez J; Serrano M; Jorcano JL
J Biol Chem; 2001 Nov; 276(47):44203-11. PubMed ID: 11551927
[TBL] [Abstract][Full Text] [Related]
17. Specific Deletion of p16
Ishida K; Tomita H; Kanayama T; Noguchi K; Niwa A; Kawaguchi M; Miyai M; Matsuo M; Imaizumi Y; Kato K; Hatano Y; Hirata A; Okada H; Shibata T; Hara A
Am J Pathol; 2020 Jun; 190(6):1332-1342. PubMed ID: 32194051
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras.
Young NP; Jacks T
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10184-9. PubMed ID: 20479239
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.
Barradas M; Anderton E; Acosta JC; Li S; Banito A; Rodriguez-Niedenführ M; Maertens G; Banck M; Zhou MM; Walsh MJ; Peters G; Gil J
Genes Dev; 2009 May; 23(10):1177-82. PubMed ID: 19451218
[TBL] [Abstract][Full Text] [Related]
20. C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf).
Ewing SJ; Zhu S; Zhu F; House JS; Smart RC
Cell Death Differ; 2008 Nov; 15(11):1734-44. PubMed ID: 18636078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
